Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Allen

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Breast Cancer Research and Treatment|March 8, 2002
In vitro cytotoxicity of bismuth-213 (213Bi)-labeled-plasminogen activator inhibitor type 2 (alpha-PAI-2) on human breast cancer cellsM Ranson, Z Tian, N M Andronicos, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 7, 2003
In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancerS M Rizvi, B J Allen, Z Tian, et al.
Leukemia Research|December 6, 2001
In vitro testing of the leukaemia monoclonal antibody WM-53 labeled with alpha and beta emitting radioisotopesSyed M Abbas Rizvi, A J Henniker, G Goozee, et al.
Asia Pacific Journal of Clinical Nutrition|January 8, 2014
Role of body protein as a prognostic indicator in wasting diseaseB J Allen, C A Pollock, J Russell, et al.
American Heart Journal|May 1, 1992
Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesiumL T Iseri, B J Allen, M L Ginkel, et al.
Cancer Research|April 15, 1993
Loss of differentiation control in transformed 3T3 T proadipocytesR L Sparks, B J Allen, A I Zygmunt, et al.
Breast Cancer Research and Treatment|January 5, 2000
Changes in body composition during breast cancer chemotherapy with the CMF-regimenA Aslani, R C Smith, B J Allen, et al.
Physics in Medicine and Biology|October 1, 1991
A total body nitrogen facility for paediatric useL A Baur, B J Allen, A Rose, et al.
British Journal of Cancer|March 20, 2003
Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2B J Allen, Z Tian, S M A Rizvi, et al.
Acta Diabetologica|November 18, 2003
Effects of 20-mg oestradiol implant therapy on bone mineral density, fat distribution and muscle mass in postmenopausal womenR D Hansen, C Raja, R J Baber, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Breast Cancer Research and Treatment|March 8, 2002
In vitro cytotoxicity of bismuth-213 (213Bi)-labeled-plasminogen activator inhibitor type 2 (alpha-PAI-2) on human breast cancer cellsM Ranson, Z Tian, N M Andronicos, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 7, 2003
In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancerS M Rizvi, B J Allen, Z Tian, et al.
Leukemia Research|December 6, 2001
In vitro testing of the leukaemia monoclonal antibody WM-53 labeled with alpha and beta emitting radioisotopesSyed M Abbas Rizvi, A J Henniker, G Goozee, et al.
Asia Pacific Journal of Clinical Nutrition|January 8, 2014
Role of body protein as a prognostic indicator in wasting diseaseB J Allen, C A Pollock, J Russell, et al.
American Heart Journal|May 1, 1992
Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesiumL T Iseri, B J Allen, M L Ginkel, et al.
Cancer Research|April 15, 1993
Loss of differentiation control in transformed 3T3 T proadipocytesR L Sparks, B J Allen, A I Zygmunt, et al.
Breast Cancer Research and Treatment|January 5, 2000
Changes in body composition during breast cancer chemotherapy with the CMF-regimenA Aslani, R C Smith, B J Allen, et al.
Physics in Medicine and Biology|October 1, 1991
A total body nitrogen facility for paediatric useL A Baur, B J Allen, A Rose, et al.
British Journal of Cancer|March 20, 2003
Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2B J Allen, Z Tian, S M A Rizvi, et al.
Acta Diabetologica|November 18, 2003
Effects of 20-mg oestradiol implant therapy on bone mineral density, fat distribution and muscle mass in postmenopausal womenR D Hansen, C Raja, R J Baber, et al.
Pageof 16